XtalPi Forms Strategic Partnership with ABB Robotics to Automate Lab Workstations in China
Sino-US AI drug development company XtalPi (QuantumPharm, HKG: 2228) has entered into a strategic partnership...
Deals
Mindray Partners with WakeMed for Comprehensive Patient Monitoring Solutions
Shenzhen-based medtech company Mindray has announced a procurement agreement with WakeMed Health & Hospitals in...
China Grand Pharma to Acquire 63% Stake in Duoputai for RMB 442 Million
China Grand Pharmaceutical and Healthcare Holdings Ltd (HKG: 0512; CGP) has announced its intention to...
Novartis Acquires Calypso Biotech for USD 250 Million to Bolster IL-15 Pipeline
Novartis (NYSE: NVS) has finalized an agreement to acquire Netherlands-based Calypso Biotech, a 2013 spinout...
Cytokinetics Attracts Big Pharma Interest Amid Aficamten’s Phase III Success
Cytokinetics (NASDAQ: CYTK), a specialist in cardiovascular diseases, is reportedly attracting interest from multiple Big...
BioNTech Acquires Pre-Clinical Asset and ADC Technology from Portuguese Biotech CellmAbs
Germany’s BioNTech (NASDAQ: BNTX) has licensed a pre-clinical antibody candidate and additional antibody-drug conjugate (ADC)...
NVIDIA Expands Healthcare Reach with Amgen’s deCode Partnership at JP Morgan Conference
At the recent JP Morgan Healthcare Conference, US chip giant NVIDIA (NASDAQ: NVDA) announced a...
Alphabet’s Isomorphic Labs Inks Pharma Partnerships with Eli Lilly and Novartis
Isomorphic Labs, a drug discovery company under the umbrella of Google’s parent group Alphabet (NASDAQ:...
Boai NKY Medical Holdings Partners with HuaDao Biopharma for CAR-T Therapy Incubator
Boai NKY Medical Holdings Ltd (SHE: 300109), a Chinese biotech company, has announced a strategic...
Shanghai’s EnjoSim Secures Tens of Millions in Pre-Series A Funding for Expansion
EnjoSim, a Shanghai-based developer of microbiologic self-administration systems, has reportedly secured tens of millions of...
Pfizer Eyes Further ADC Expansion, Potentially in China, Says Chief Oncology Officer
Dr. Chris Boshoff, Pfizer (NYSE: PFE)’s recently appointed chief oncology officer, disclosed in an interview...
Myrobalan Therapeutics Secures $24 Million in Series A Funding with Strong Chinese Investor Support
Myrobalan Therapeutics, a Massachusetts-based biotech firm, has successfully completed a $24 million Series A funding...
CORXEL Secures Licensing Rights for Biogen’s BIIB131 in Stroke Treatment
Shanghai-based CORXEL, formerly known as Ji Xing Pharmaceuticals, supported by RTW Investments, has secured a...
Keylights Biotechnology Raises $14 Million in Series B to Expand IVD Instrument Range
Keylights Biotechnology Co., Ltd., a leading in vitro diagnostic (IVD) instruments manufacturer headquartered in Shenzhen,...
Gansu Deshengtang Partners with RELEX Solutions to Enhance Supply Chain Efficiency
Gansu Deshengtang Medical Science and Technology Group Co., Ltd, a prominent Chinese healthcare group, has...
China Resources Medical Laboratory Partners with Qlife Lab for Comprehensive Mass Spectrometry Solutions
China Resources Medical Holdings Company Limited’s subsidiary, China Resources (Guangdong) Medical Laboratory Co., Ltd, has...
WuXi Biologics Partners with BioNTech to Develop Next-Gen Antibodies in $20 Million Deal
WuXi Biologics (HKG: 2269), a China-based Contract Research, Development, and Manufacturing Organization (CRDMO), has entered...
Junshi Biosciences Regains Global Rights to JS006 as Coherus Terminates Licensing Agreement
Junshi Biosciences (HKG: 1877; SHA: 688180), based in Suzhou, has announced the termination of its...
Amgen Licenses XeriJect Technology from Xeris Biopharma for Subcutaneous Tepezza Development
Amgen (NASDAQ: AMGN) has entered into a licensing agreement with Xeris Biopharma (NASDAQ: XERS) for...
Henlius Biotech Secures Exclusive Rights to Sermonix’s Lasofoxifene for Breast Cancer Treatment in China
Shanghai Henlius Biotech Inc. (HKG: 2696) has entered into a partnership and licensing agreement with...